Anti-TNF-alpha antibodies and their uses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9315573
APP PUB NO 20140212424A1
SERIAL NO

14194090

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to antibodies directed to the tumor necrosis factor alpha (“TNF-α”) and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of TNF-α.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE BIOTHERAPEUTICS INCREDWOOD CITY CA 94063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akamatsu, Yoshiko Palo Alto, US 21 172
Dubridge, Robert B Belmont, US 54 1524
Harding, Fiona A Santa Clara, US 62 404
Powers, David B Fairfax, US 19 269

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 19, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00